Skip to main content

Table 3 Whole brain atrophy rates for subjects treated with placebo and with galantamine

From: The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial

  Placebo Galantamine Adjusted mean difference 95% CI
Whole brain atrophy rate 0.63 0.46 0.17 0.04 to 0.30
Hippocampal atrophy rate 1.70 1.94 −0.24 −0.62 to 0.12
  1. Data presented as percentage change per year. The numbers of subjects per cell are as follows: whole brain atrophy rate, total n = 242 (placebo, n = 130; galantamine, n = 112); hippocampal atrophy rate, total n = 302 (placebo, n = 160; galantamine, n = 142). CI, confidence interval.